Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Woodnutt

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Drug Discovery & Development|October 24, 2008
Advances in protein therapeuticsGary Woodnutt, Bernard Violand, Michael North
Nature Reviews. Cancer|July 24, 2010
Targeting the ANGPT-TIE2 pathway in malignancyHanhua Huang, Abhijit Bhat, Gary Woodnutt, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzaeValerie Berry, Jennifer Hoover, Christine Singley, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2004
Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agentAnthony R White, Clive Kaye, James Poupard, et al.
Scientific Reports|January 25, 2013
Peptide-conjugation induced conformational changes in human IgG1 observed by optimized negative-staining and individual-particle electron tomographyHuimin Tong, Lei Zhang, Allan Kaspar, et al.
Journal of Proteome Research|June 15, 2005
Global proteome discovery using an online three-dimensional LC-MS/MSJing Wei, Jun Sun, Wen Yu, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
Ex vivo pharmacodynamics of amoxicillin-clavulanate against beta-lactamase-producing Escherichia coli in a yucatan miniature pig model that mimics human pharmacokineticsStéphane Bronner, Valérie Murbach, Jean-Daniel Peter, et al.
Journal of Molecular Biology|February 17, 2005
Structural characterization of the cell wall binding domains of Clostridium difficile toxins A and B; evidence that Ca2+ plays a role in toxin A cell surface associationStephen J Demarest, Jared Salbato, Marikka Elia, et al.
Methods in Enzymology|November 2, 2005
High-throughput cultivation of microorganisms using microcapsulesKarsten Zengler, Marion Walcher, Greg Clark, et al.
Cancer|October 12, 2016
A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinomaSumanta K Pal, Harry A Drabkin, James A Reeves, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Drug Discovery & Development|October 24, 2008
Advances in protein therapeuticsGary Woodnutt, Bernard Violand, Michael North
Nature Reviews. Cancer|July 24, 2010
Targeting the ANGPT-TIE2 pathway in malignancyHanhua Huang, Abhijit Bhat, Gary Woodnutt, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzaeValerie Berry, Jennifer Hoover, Christine Singley, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2004
Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agentAnthony R White, Clive Kaye, James Poupard, et al.
Scientific Reports|January 25, 2013
Peptide-conjugation induced conformational changes in human IgG1 observed by optimized negative-staining and individual-particle electron tomographyHuimin Tong, Lei Zhang, Allan Kaspar, et al.
Journal of Proteome Research|June 15, 2005
Global proteome discovery using an online three-dimensional LC-MS/MSJing Wei, Jun Sun, Wen Yu, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
Ex vivo pharmacodynamics of amoxicillin-clavulanate against beta-lactamase-producing Escherichia coli in a yucatan miniature pig model that mimics human pharmacokineticsStéphane Bronner, Valérie Murbach, Jean-Daniel Peter, et al.
Journal of Molecular Biology|February 17, 2005
Structural characterization of the cell wall binding domains of Clostridium difficile toxins A and B; evidence that Ca2+ plays a role in toxin A cell surface associationStephen J Demarest, Jared Salbato, Marikka Elia, et al.
Methods in Enzymology|November 2, 2005
High-throughput cultivation of microorganisms using microcapsulesKarsten Zengler, Marion Walcher, Greg Clark, et al.
Cancer|October 12, 2016
A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinomaSumanta K Pal, Harry A Drabkin, James A Reeves, et al.
Pageof 2